Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Few ‘high-quality’ healthcare markets exist

Only a handful of healthcare markets have been given high star ratings by CMS across four different sectors, according to a study published in The BMJ, suggesting either high-quality care at one facility isn’t “dependent on or improves” quality in another or the ratings themselves are flawed.

Inova CEO Knox Singleton Announces Retirement

Knox Singleton, 69, the longtime CEO of Inova, Northern Virginia's largest private employer, announced he will be retiring July 1st, 2018, completing 35 years of growth for what has become a world-class healthcare system now serving more than two million patients a year.

CBO: Uncertainty to blame for 15% average premium hike on ACA exchanges

Average premiums for health plans purchased on the Affordable Care Act (ACA) will be 15 percent higher in 2018, according to the Congressional Budget Office (CBO), largely due to how the administration of President Donald Trump has managed the law.

Linda Pauliks, M.D., Named Medical Director of Pediatric & Congenital Cardiac Imaging at Miller Children's & Women's Hospital Long Beach

Miller Children's & Women's Hospital Long Beach has named Linda Pauliks, M.D., a pediatric cardiologist and expert in cardiac imaging, as medical director of pediatric and congenital cardiac imaging.

Thumbnail

New AAFP president pledges to ‘hound Congress’ on administrative relief for practices

Michael Munger, MD, assumed the role of president of the American Academy of Family Physicians (AAFP) during its 2017 Family Medicine Experience (FMX) in San Antonio, Texas. In his opening speech, he both praised the progress in moving toward value-based care and echoed members’ angst about the increasing administrative burden in their practices.

Advances in 3D printing could mean personalized medications

3D printing has already provided printed prosthetics and organ models but that is just the tip of the iceberg. As the number of people utilizing 3D-printed items increases, the healthcare industry is preparing for a surge of new realizations.

Thumbnail

5 things to know about the Graham-Cassidy ACA repeal bill

Amid attempts to agree on short-term stabilization of the Affordable Care Act (ACA) and Democrats coming out in support for a “Medicare-for-all” bill, a group of Republican senators unveiled what could be their last chance to repeal and replace the ACA.

University of Texas, Ardent Health to acquire 10-hospital system in joint venture

The East Texas Medical Center (ETMC) Regional Healthcare System will be acquired by a new joint venture between Nashville-based Ardent Health System and the University of Texas (UT) System, the two announced in a Sept. 13 press release, with Ardent assuming control of day-to-day operations.

Displaying 4233 - 4240 of 6649

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup